Longboard Pharmaceuticals, Inc. (Longboard) is a biopharmaceutical company focused on developing transformative medicines for neurological diseases. It specializes in centrally acting product candidates designed to be highly selective for specific G protein-coupled receptors (GPCRs). The company also develops treatment of neurodegenerative diseases associated with neuroinflammation, nervous system neuroinflammatory diseases as well as developmental and epileptic encephalopathies (DEEs).